Madrigal Pharmaceuticals, Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2009 | — | — | $44.2M |
| FY2010 | $30.6M | $54.1M | $31.3M |
| FY2011 | $27.6M | $42.3M | $30.1M |
| FY2012 | $28.0M | $103.0M | $81.5M |
| FY2013 | $46.1M | $95.2M | $48.5M |
| FY2014 | $35.5M | $100.7M | $148.1K |
| FY2015 | $49.3M | $363.6K | $306.0K |
| FY2016 | $4.8M | $41.2M | $19.1M |
| FY2017 | $10.1M | $192.3M | $148.6M |
| FY2018 | $8.4M | $485.4M | $57.4M |
| FY2019 | $25.5M | $442.1M | $46.7M |
| FY2020 | $47.0M | $287.0M | $54.0M |
| FY2021 | $77.2M | $273.3M | $36.3M |
| FY2022 | $165.2M | $362.6M | $331.5M |
| FY2023 | $235.2M | $640.5M | $99.9M |
| FY2024 | $287.9M | $1.04B | $100.0M |
| FY2025 | $656.9M | $1.26B | $198.7M |